China SXT Pharmaceuticals (SXTC) Total Debt (2018 - 2026)
China SXT Pharmaceuticals (SXTC) posted quarterly Total Debt of $999565.0 for Q1 2026, up 851.56% year-over-year from $105045.0 in Q1 2025, and up 1188.48% quarter-over-quarter from $77577.0 in Q3 2025.
China SXT Pharmaceuticals (SXTC) Total Debt (2018 - 2026) Analysis & Trends
China SXT Pharmaceuticals' Total Debt history runs 9 years deep, the most recent figure standing at $999565.0 for Q1 2026.
- In Q1 2026, Total Debt rose 851.56% year-over-year to $999565.0; the TTM figure through Mar 2026 stood at $999565.0 (up 851.56% YoY), while the FY2026 annual figure was $999565.0, up 851.56% from the prior year.
- Total Debt for Q1 2026 stood at $999565.0, up from $77577.0 in the prior quarter.
- The five-year high for Total Debt was $1.2 million in Q3 2022, with the low at $77577.0 in Q3 2025.
- The 5-year median for Total Debt is $610183.0 (2024), against an average of $594175.4.
- The sharpest annual moves came in 2022 and 2026: Total Debt slumped 95.33% in 2022, then soared 851.56% in 2026.
- China SXT Pharmaceuticals' Total Debt stood at $1.2 million in 2022, then sank by 90.68% to $112397.0 in 2023, then soared by 627.36% to $817528.0 in 2024, then tumbled by 90.51% to $77577.0 in 2025, then surged by 1188.48% to $999565.0 in 2026.
- Business Quant data shows SXTC's Total Debt at $999565.0 in Q1 2026, $77577.0 in Q3 2025, and $105045.0 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - | -5.81 Bn |
| 2 | Teva Pharmaceutical Industries | 42.98 Bn | 39.32 Bn | 2.15 Bn | 16.59 Bn |
| 3 | Zoetis | 31.53 Bn | 29.86 Bn | 1.05 Bn | 9.05 Bn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | 31.47 Bn |
| 5 | United Therapeutics | 22.16 Bn | 19.49 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.74 Bn | 17.85 Bn | 1.46 Bn | 13.35 Bn |
| 7 | Neurocrine Biosciences | 15.51 Bn | 15.12 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 3.92 Bn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.95 Bn | - | 760.00 Mn |
| 10 | China SXT Pharmaceuticals | 30,925.44 | -28.15 Mn | - | 999,565.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 999,565.00 |
| Sep 30, 2025 | 77,577.00 |
| Mar 31, 2025 | 105,045.00 |
| Sep 30, 2024 | 817,528.00 |
| Mar 31, 2024 | 610,183.00 |
| Sep 30, 2023 | 112,397.00 |
| Mar 31, 2023 | 285,315.00 |
| Sep 30, 2022 | 1.21 Mn |
| Mar 31, 2022 | 1.13 Mn |
| Sep 30, 2021 | 2.12 Mn |
| Mar 31, 2021 | 24.30 Mn |
| Sep 30, 2020 | 60,970.00 |
| Mar 31, 2020 | 6.68 Mn |
| Sep 30, 2019 | 1.89 Mn |
| Mar 31, 2019 | 2.52 Mn |
| Sep 30, 2018 | 205,452.00 |